Stock Screener App

Gratuito -

Installare

Drug Manufacturers - Major

91.35

0.23% -0.21

after-market

Dopo l'orario di chiusura: 90.76 -0.59 -0.65%

Astrazeneca PLC (AZN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché AZN Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Astrazeneca PLC Borsa (AZN) Ultime notizie

AstraZeneca Gets FDA Nod For Breast Cancer Drug, EU Clearance For Lupus Pen - Benzinga

AstraZeneca (AZN) Receives EU Approval for Saphnelo Self-Adminis - GuruFocus

AstraZeneca receives EU approval for subcutaneous Saphnelo self-administration - Investing.com India

AstraZeneca PLCEnhertu approved in US for 1L HER2+ metastatic BC - Research Tree

AstraZeneca chalks up dual regulatory wins in cancer and immunology - Vox Markets

AstraZeneca update within FTSE 350 and FTSE 100 healthcare landscape - Kalkine Media

AstraZeneca and Daiichi Sankyo's Enhertu approved as first-line therapy for HER2+ breast cancer - marketscreener.com

AstraZeneca’s Saphnelo approved in EU for self-administration in lupus By Investing.com - Investing.com UK

AstraZeneca Receives EU Approval for Pre-filled Pen for Lupus - marketscreener.com

AstraZeneca says subcutaneous Saphnelo approved in EU - marketscreener.com

REGAstraZeneca PLCSubcutaneous Saphnelo approved in EU - TradingView — Track All Markets

AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in US - marketscreener.com

AstraZeneca, Daiichi Sankyo's Enhertu Combination Gets US Approval for Breast Cancer Treatment - marketscreener.com

AstraZeneca Withdraws Andexxa, Unable To Find Path Forward With US FDA - Citeline News & Insights

AstraZeneca PLC ADR Underperforms Monday When Compared To Competitors Despite Daily Gains - 富途牛牛

AstraZeneca (AZN) and Daiichi Sankyo's Enhertu Combo Gains FDA A - GuruFocus

AstraZeneca (AZN) Gains FDA Approval for Breast Cancer Treatment - GuruFocus

AstraZeneca's Enhertu and Genentech's Perjeta combo gains breast cancer approval - Seeking Alpha

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment - Reuters

AstraZeneca and Daiichi Sankyo's enhertu gets US cancer approval - marketscreener.com

AstraZeneca (AZN) Gains FDA Approval for Enhertu in Breast Cance - GuruFocus

Geneos Wealth Management Inc. Grows Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

Holocene Advisors LP Sells 124,752 Shares of AstraZeneca PLC $AZN - MarketBeat

Rexford Capital Inc. Invests $948,000 in AstraZeneca PLC $AZN - MarketBeat

AstraZeneca Unveils Sweeping Blood Cancer Push With Record ASH Presence - MyChesCo

Why is AstraZeneca PLC (AZN) one of the best pharma stocks to invest in? - MSN

AstraZeneca PLC $AZN Shares Bought by Cubist Systematic Strategies LLC - MarketBeat

AstraZeneca PLC $AZN Shares Bought by BI Asset Management Fondsmaeglerselskab A S - MarketBeat

GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients - Benzinga

AstraZeneca (AZN) At the Center of Serious Analyst Attention - Insider Monkey

Parkwood LLC Buys 112,053 Shares of AstraZeneca PLC $AZN - MarketBeat

Federated Hermes Inc. Has $10.83 Million Stake in AstraZeneca PLC $AZN - MarketBeat

Swedish Stocks in North America – AstraZeneca Drops 0.8 Percent - marketscreener.com

AstraZeneca PLC ADR Falls Thursday, Underperforms Market - 富途牛牛

Details trickle in about salary, size at AstraZeneca's new Albemarle plant - Richmond Times-Dispatch

Is the Market Bullish or Bearish on AstraZeneca PLC? - Benzinga

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.01 Million Stake in AstraZeneca PLC $AZN - MarketBeat

Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In? - Insider Monkey

AstraZeneca: A Rare Compound Growth Opportunity In Biopharma (AZN) - Seeking Alpha

60,378 Shares in AstraZeneca PLC $AZN Bought by Norges Bank - MarketBeat

Aug Ideas: Will Precidian ETFs Trust AstraZeneca PLC stock maintain strong growthJuly 2025 Sector Moves & Smart Allocation Stock Reports - moha.gov.vn

AstraZeneca price target raised to $105 from $95 at TD Cowen on growth outlook - Investing.com UK

AstraZeneca (AZN) Begins Phase 3 Trial of Enhertu for Ovarian Ca - GuruFocus

Quantbot Technologies LP Reduces Stake in AstraZeneca PLC $AZN - MarketBeat

AstraZeneca PLC $AZN Shares Sold by Hsbc Holdings PLC - MarketBeat

Cerity Partners LLC Increases Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

AstraZeneca PLC $AZN Shares Acquired by Fayez Sarofim & Co - MarketBeat

AstraZeneca (LSE:AZN): Assessing Valuation After a Strong Year-to-Date Share Price Rally - Yahoo Finance

AstraZeneca PLC (NASDAQ:AZN) Nasdaq Futures Science-Driven Growth - Kalkine Media

AstraZeneca PLC ADR Rises Monday, Outperforms Market - 富途牛牛

Pillar Biosciences and AstraZeneca expand liquid biopsy access partnership to China - marketscreener.com

Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China - marketscreener.com

AstraZeneca is top pharma tip for 2026, with GSK left trailing - Proactive Investors

How Are AstraZeneca’s Scientific Initiatives Influencing Its FTSE 100 Standing? - Kalkine Media

AstraZeneca (AZN) Price Target Raised by JPMorgan - GuruFocus

First Trust Advisors LP Acquires 217,595 Shares of AstraZeneca PLC $AZN - MarketBeat

AstraZeneca PLC $AZN Shares Bought by Invesco Ltd. - MarketBeat

CW Advisors LLC Increases Stake in AstraZeneca PLC $AZN - MarketBeat

1832 Asset Management L.P. Acquires 18,543 Shares of AstraZeneca PLC $AZN - MarketBeat

Surprises Report: Is AstraZeneca PLC ZEG stock resilient in recession scenariosLong Setup & High Accuracy Investment Signals - BỘ NỘI VỤ

AstraZeneca PLC $AZN Shares Sold by Capital Fund Management S.A. - MarketBeat

AstraZeneca: An Insight Into The Growth Potential Of Imfinzi - Smartkarma

SCS Capital Management LLC Purchases 142,331 Shares of AstraZeneca PLC $AZN - MarketBeat

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters